Procaps Group S.A. (NASDAQ:PROC) Short Interest Update

Procaps Group S.A. (NASDAQ:PROC) saw a significant decline in short interest during the month of June. As of June 30th, there was short interest totalling 6,800 shares, a decline of 24.4% from the June 15th total of 9,000 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average trading volume of 5,200 shares, the days-to-cover ratio is currently 1.3 days.

Procaps Group Stock Up 2.4 %

Procaps Group stock traded up $0.06 during trading on Friday, reaching $2.57. The stock had a trading volume of 8,683 shares, compared to its average volume of 3,205. Procaps Group has a 52-week low of $1.95 and a 52-week high of $4.95. The business has a 50 day moving average price of $2.65 and a 200 day moving average price of $3.13.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.